SmartHeart

Are Traditional Preclinical Models Limiting Your Research? Leading Experts Explain Why Human-Based Models Matter

Learn how human-based models like iPSC-derived cardiomyocytes and 3D organoid systems improve translational outcomes in academic drug discovery.

15 sept.9 min de lecture

FDA NAMs Roadmap: Economic and Scientific Impact on Preclinical Drug Safety

9 sept.6 min de lecture

Cardiac organoids finally solve drug development's costliest problem by predicting human heart responses animal testing missed completely.

4 sept.5 min de lecture